According to The Guardian, several hospitals have begun using the PinPoint blood test following a trial involving 16,481 patients from 170 GP practices across Yorkshire.
Among them were 3,313 women who had been referred for further examination because of postmenopausal bleeding.
The blood test uses artificial intelligence to analyze 30 different substances in the blood.
The results showed an accuracy rate of 99 percent, both for detecting cancer and for ruling out the disease, The Guardian reports.
Also read: How to effectively disinfect your home after illness
More hospitals are adopting the test
Based on the trial results, Mid Yorkshire NHS Teaching Trust and Leeds Teaching Hospitals NHS Trust will begin using the test as part of the diagnostic pathway for, among other conditions, gynecological cancers.
At the same time, Cancer Research UK believes the test appears promising.
However, the organization stresses that more research is needed before its full benefits for patients and the healthcare system can be determined.
Could spare many women
Each year, around 90,000 women in England are examined for possible uterine cancer because they experience postmenopausal bleeding.
Also read: New test detects oral cancer with nearly 96 percent accuracy
Only about one in ten is diagnosed with cancer, while most undergo a transvaginal ultrasound scan, according to The Guardian.
The trial suggests that the blood test could allow around one in five referred women to avoid this examination.
This could spare many women an uncomfortable experience while enabling hospitals to examine and treat the patients who do have cancer more quickly.
Also read: Adults with ADHD had fewer symptoms after 12 weeks of exercise
Also read: These types of medication can cause problems in the sun